Clinical Trial Update: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing preliminary efficacy, safety, and pharmacokinetics of subcutaneous JS005 in Chinese adults with active ankylosing spondylitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Ankylosing Spondylitis
• Ankylosing Spondylitis

Drugs mentioned

• JS005

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Active Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN